Dupilumab Sustains Atopic Dermatitis Efficacy at 5 Years
An open-label extension trial shows dupilumab provides similar skin clearance and itch benefit at 5 years as it had at 1 year of treatment.
Source: hcplive.com
Lisaa Beck News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lisaa Beck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lisaa Beck Today - Breaking & Trending Today
Lebrikizumab, Corticosteroid Regimen May Benefit Eczema After Dupilumab Discontinuation
Post-hoc data from the phase 3 ADhere trial shows a lebrikizumab regimen may help patients with atopic dermatitis achieve skin clearance they could not with dupilumab.
Source: hcplive.com
The Leadership Institute at Purdue Northwest announces 2021-22 Leadership Northwest Indiana graduates
The Leadership Institute at Purdue University Northwest (PNW) congratulates 27 professionals on their completion of the 2021-22 LNI program.
Source: pnw.edu